Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
01/2007
01/18/2007US20070015282 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
01/18/2007US20070015271 Human secreted proteins
01/18/2007US20070015269 Crystals of DPP-IV
01/18/2007US20070015268 Entrapping immobilization pellets and process for producing the same
01/18/2007US20070015266 Using amylase to hydrolyze starch for use in fermentation of ethanol
01/18/2007US20070015265 Derived from Achromobacter xylosoxidans; improved thermostability, storage stability and cost efficiency; industrial scale production of a 2-keto-3-deoxyaldonic acid
01/18/2007US20070015263 Method for increasing yield of biomass of and/or components of biomass from marine microorganisms
01/18/2007US20070015261 Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals
01/18/2007US20070015260 Synthesis of synthons for the manufacture of bioactive compounds
01/18/2007US20070015256 molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; cell comprising the recombinant expression vector
01/18/2007US20070015255 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
01/18/2007US20070015252 Corynebacterium glutamicum genes encoding regulatory proteins
01/18/2007US20070015251 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins
01/18/2007US20070015249 Chondroitin polymerase and DNA encoding the same
01/18/2007US20070015248 Expression vector and use thereof
01/18/2007US20070015245 Production of a highly active, soluble form of the cytochrome P450 reductase (CPR A) from Candida tropicalis
01/18/2007US20070015244 System for antibody expression and assembly
01/18/2007US20070015241 Sulfur atom-free enzyme protein
01/18/2007US20070015237 Production of carotenoids in oleaginous yeast and fungi
01/18/2007US20070015236 Process of preparing prednisolone devoid of steroid-derived impurities using recombinant E. coli transformed with A delta¹-dehydrogenase gene
01/18/2007US20070015220 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins
01/18/2007US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal
01/18/2007US20070015217 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease
01/18/2007US20070015198 DNA sequence detection of nucleated red blood cells
01/18/2007US20070015185 Lysis and stabilization buffer suitable for inclusion in PCR reactions
01/18/2007US20070015177 Nucleic acid extraction method
01/18/2007US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
01/18/2007US20070015163 Novel full-length cDNA
01/18/2007US20070015156 Aberrantly methylated genes in pancreatic cancer
01/18/2007US20070014890 Genetically-modified yeasts which can float in a liquid medium, production method thereof and use of same
01/18/2007US20070014817 Methods for detecting virulent Plasmodium, for evaluating Plasmodium virulence, and for screening new drugs employing the 3'UTR of Plasmodium SUB2 and the Plasmodium SUB2 serine protease
01/18/2007US20070014809 B Cell Activation and Polypeptides Having CD14 Activity
01/18/2007US20070014769 Adenovirus vectors comprising meganuclease-type endonucleases, and related systems
01/18/2007CA2621359A1 Polysaccharide produced by microorganism belonging to genus bifidobacterium
01/18/2007CA2615057A1 Compositions and methods for biocatalytic engineering
01/18/2007CA2614368A1 Debaryomyces castellii phytase
01/18/2007CA2612423A1 A novel stabilized liquid yeast preparation, a method for producing the same, and the use thereof
01/18/2007CA2510657A1 Polypeptides with an activity in the mtbe degradation pathway and their use
01/17/2007EP1743942A1 Recombinant virus vector for gene introduction in lymphocyte
01/17/2007EP1743941A1 Novel mite allergen
01/17/2007EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
01/17/2007EP1743938A1 Means and methods for displaying polypeptides on cells
01/17/2007EP1743881A1 Phenyl-benzyl-ketones
01/17/2007EP1743042A1 Lactic acid bacteria strains exhibiting probiotic properties and compositions comprising the same
01/17/2007EP1742728A1 Microbial encapsulation
01/17/2007EP1742656A2 Novel peanut skin extract as a vaccine adjuvant
01/17/2007EP1504095B1 Site specific listeria integration vectors and methods for using the same
01/17/2007EP1368474B1 Polynucleotide useful for modulating cancer cell proliferation
01/17/2007EP1349945B1 Method for the production of a heterologous protein by a fungus
01/17/2007EP1330516B1 Surface transfection and expression procedure
01/17/2007EP1326995B1 Method for synthesising peptides, peptide mimetics and proteins
01/17/2007EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
01/17/2007EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon
01/17/2007EP1259628B1 Methods for generating hypermutable yeast
01/17/2007EP1206556B1 Signal peptides isolated from lactococcus lactis
01/17/2007EP1179539B1 Protein having hemolytic activity and gene encoding the protein
01/17/2007EP0977896B1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
01/17/2007CN1898387A Expression vector and its use for an antibiotic free expression
01/17/2007CN1898383A Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same
01/17/2007CN1898376A Cryo-protective agents for microorganisms
01/17/2007CN1896246A Engineering of metabolic control
01/17/2007CN1896245A Production of gene recombinant fusion protein K1-EN
01/17/2007CN1896242A Gene of chlorine-resisting strain S616
01/17/2007CN1896238A Genic engineering strain of expression recombinant prawn peptide Pen24 and its use
01/17/2007CN1896232A Ginkgo endogenous fusanin plasminogen, its production and use
01/17/2007CN1896231A Method for separating tetramer uric acid oxydiazing enzyme
01/17/2007CN1896230A Fi-C31 integrase modified TAT and NLS polypeptide and its use
01/17/2007CN1896226A Midecamycin hyper producing strain
01/17/2007CN1896225A Liquid-cultured flesh lucid ganoderma, and production of flesh lucid ganoderma nutrient liquid by culturing liquid
01/17/2007CN1896224A Fermented cordycepin micrograin, its production and use
01/17/2007CN1896016A Use of chlorine-resisting strain S616
01/17/2007CN1895294A Chinese pilose spore concentrated oral liquid
01/17/2007CN1295331C Oncogene, recombinant protein derived therefrom, and uses thereof
01/17/2007CN1295324C Saprospira sp. and its application
01/17/2007CN1295323C High density culturing method of alexandrium tamarense
01/17/2007CN1294988C Buckwheat trypsase inhibitor, expression and application thereof
01/17/2007CN1294828C Producing method of red rice fat reducing tea
01/17/2007CN1294827C Preparing process of antihyperglycemic tea with functions of inhibiting cholesterol synthesis
01/16/2007US7164000 RANTES mutants and therapeutic applications thereof
01/16/2007US7163923 Peptide deformylase activated prodrugs
01/16/2007US7163820 genetic element (plasmid) of that strain responsible for enterotoxin (STa, STb) production was removed, while the toxin-negative Escherichia coli strain EC2173 (NBI/36) could retain the ability to produce its original fimbriae (F18ac) facilitating its intestinal colonization
01/16/2007US7163817 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for their preparation
01/16/2007US7163816 Alpha-amylase variants
01/16/2007US7163815 Methods and compositions for NAD(P)(H) oxidases
01/16/2007US7163814 Modified reductase and its gene, and use thereof
01/16/2007US7163813 Biological compositions and methods for treatment of colorectal cancer
01/16/2007US7163811 production of highly unsaturated fatty acids, including DHA, by marine microorganisms at low pH levels under non-corrosive conditions
01/16/2007US7163810 Method for producing target substance
01/16/2007US7163805 Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein
01/16/2007US7163804 Non-toxic non-toxigenic non-pathogenic fusarium expression system
01/16/2007US7163797 50 human secreted proteins
01/16/2007US7163795 Methods and compositions for pearl oyster cultivation
01/16/2007US7163791 α,2,8-sialyltransferase
01/16/2007CA2366065C Topical cosmetic composition comprising bifidobacterium and plant extracellular matrix
01/13/2007CA2550903A1 Guinea pig chymase
01/11/2007WO2007005646A2 Recombinant host cells and media for ethanol production
01/11/2007WO2007004966A1 USE OF LACTOBACILLUS FOR INCREASING THE ABSORPTION OF A METAL CHOSEN FROM Fe, Zn, Ca AND IONS THEREOF
01/11/2007WO2007004694A1 Novel gene involved in biosynthesis of petroselinic acid and process for production of petroselinic acid
01/11/2007WO2007004654A1 Mutant pcna
01/11/2007WO2007004538A1 Method for production of recombinant protein